Altre lingue Vanda Pharmaceuticals Inc.

Azioni

VNDA

US9216591084

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 31/05/2024			Variaz. 5gg	Var. 1 gen.
5,11 ^USD	+2,00%		-2,29%	+21,09%

31/05	Vanda Pharmaceuticals commercializzerà il trattamento della sclerosi multipla negli USA	MT
27/05	Borsa di Italia: Wall Street e la City non rispondono più

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US	31/05
Borsa di Italia: Wall Street e la City non rispondono più	27/05
IN DIRETTA DAI MERCATI: Azimut, Stellantis, Generali, Leonardo, Mediobanca, Poste Italiane, Recordati, BBVA, Microsoft, Tesla, TSMC, UBS...	27/05
Vanda Pharmaceuticals rejects Future Pak's revised takeover offer	24/05
Vanda Pharmaceuticals rejects Future Pak's deal	24/05
Future Pak, Ltd. cancelled the acquisition of Vanda Pharmaceuticals Inc. from The Vanguard Group, Inc., Renaissance Technologies LLC, BlackRock, Inc., Butler Hall Capital LLC, Shareholder Capital LLC and others.	24/05
Vanda Pharmaceuticals Says Second Phase 3 Study of Tradipitant in Motion Sickness Yields 'Positive' Results	15/05
Vanda Pharmaceuticals Inc. Reports Positive Results from A Second Phase III Study of Tradipitant in Motion Sickness	15/05
Transcript : Vanda Pharmaceuticals Inc., Q1 2024 Earnings Call, May 08, 2024	08/05
Vanda Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Sector Update: Health Care Stocks Advance in Late Afternoon Trading	07/05
Sector Update: Health Care Stocks Stronger in Tuesday Afternoon Trading	07/05
Sector Update: Health Care	07/05
Vanda Pharmaceuticals Shares Rise After Future Pak Adds $260 Million Potential Payments to Cash Offer	07/05
Future Pak sweetens buyout offer for Vanda Pharmaceuticals	07/05
Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer	25/04
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents	22/04
Butler Hall Capital urges Vanda to engage in sales discussions	19/04
Deals of the day-Mergers and acquisitions	17/04
Vanda Pharmaceuticals rejects takeover proposal from Future Pak	17/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Vanda Pharmaceuticals Inc.

Azioni

VNDA

US9216591084

Altre lingue

Filtri